Global Beta-lactam and Beta-lactamase Inhibitors Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Beta-lactam and Beta-lactamase Inhibitors Market Overview

• 1.1 Product Overview and Scope of Beta-lactam and Beta-lactamase Inhibitors
• 1.2 Classification of Beta-lactam and Beta-lactamase Inhibitors by Types
  • 1.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Types in 2018
  • 1.2.3 Penicillin
  • 1.2.4 Cephalosporin
  • 1.2.5 Carbapenem
  • 1.2.6 Monobactam
  • 1.2.7 Combination
• 1.3 Global Beta-lactam and Beta-lactamase Inhibitors Market by Application
  • 1.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Oral
  • 1.3.3 Intravenous
  • 1.3.4 Others
• 1.4 Global Beta-lactam and Beta-lactamase Inhibitors Market by Regions
  • 1.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Beta-lactam and Beta-lactamase Inhibitors Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Beta-lactam and Beta-lactamase Inhibitors Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Beta-lactam and Beta-lactamase Inhibitors Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Beta-lactam and Beta-lactamase Inhibitors Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Beta-lactam and Beta-lactamase Inhibitors Status and Prospect (2014-2024)
• 1.5 Global Market Size of Beta-lactam and Beta-lactamase Inhibitors (2014-2024)

2 Company Profiles

• 2.1 Abbott Laboratories
  • 2.1.1 Business Overview
  • 2.1.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Pfizer Inc.
  • 2.2.1 Business Overview
  • 2.2.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 GlaxoSmithKline plc
  • 2.3.1 Business Overview
  • 2.3.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Allergan Plc.
  • 2.4.1 Business Overview
  • 2.4.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Novartis International AG (Sandoz)
  • 2.5.1 Business Overview
  • 2.5.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 F. Hoffmann-La Roche Ltd.
  • 2.6.1 Business Overview
  • 2.6.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Teva Pharmaceutical Industries Ltd
  • 2.7.1 Business Overview
  • 2.7.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Mylan N.V.
  • 2.8.1 Business Overview
  • 2.8.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Merck & Co. Inc.
  • 2.9.1 Business Overview
  • 2.9.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Sanofi
  • 2.10.1 Business Overview
  • 2.10.2 Beta-lactam and Beta-lactamase Inhibitors Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Sanofi Beta-lactam and Beta-lactamase Inhibitors Revenue, Gross Margin and Market Share (2017-2018)

3 Global Beta-lactam and Beta-lactamase Inhibitors Market Competition, by Players

• 3.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Beta-lactam and Beta-lactamase Inhibitors Players Market Share
  • 3.2.2 Top 10 Beta-lactam and Beta-lactamase Inhibitors Players Market Share
• 3.3 Market Competition Trend

4 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions

• 4.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Regions
• 4.2 North America Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 4.3 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 4.5 South America Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)

5 North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries

• 5.1 North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries (2014-2019)
• 5.2 USA Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 5.3 Canada Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)

6 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries

• 6.1 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries (2014-2019)
• 6.2 Germany Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 6.3 UK Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 6.4 France Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 6.5 Russia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 6.6 Italy Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries

• 7.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries (2014-2019)
• 7.2 China Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 7.3 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 7.4 Korea Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 7.5 India Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)

8 South America Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries

• 8.1 South America Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries (2014-2019)
• 8.2 Brazil Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Beta-lactam and Beta-lactamase Inhibitors by Countries

• 9.1 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 9.3 UAE Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2014-2019)

10 Global Beta-lactam and Beta-lactamase Inhibitors Market Segment by Type

• 10.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue and Market Share by Type (2014-2019)
• 10.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast by Type (2019-2024)
• 10.3 Penicillin Revenue Growth Rate (2014-2024)
• 10.4 Cephalosporin Revenue Growth Rate (2014-2024)
• 10.5 Carbapenem Revenue Growth Rate (2014-2024)
• 10.6 Monobactam Revenue Growth Rate (2014-2024)
• 10.7 Combination Revenue Growth Rate (2014-2024)

11 Global Beta-lactam and Beta-lactamase Inhibitors Market Segment by Application

• 11.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2014-2019)
• 11.2 Beta-lactam and Beta-lactamase Inhibitors Market Forecast by Application (2019-2024)
• 11.3 Oral Revenue Growth (2014-2019)
• 11.4 Intravenous Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2024)

• 12.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2024)
• 12.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast by Regions (2019-2024)
• 12.3 North America Beta-lactam and Beta-lactamase Inhibitors Revenue Market Forecast (2019-2024)
• 12.4 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue Market Forecast (2019-2024)
• 12.6 South America Beta-lactam and Beta-lactamase Inhibitors Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology